Nevan J. Krogan

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Whole exome sequencing in individuals with obsessive-compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes

  Open MIND · 2026-06-23

• Whole exome sequencing in individuals with obsessive-compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes

  Zenodo (CERN European Organization for Nuclear Research) · 2026-06-23

• Figure S3 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

  2026-06-17

• Figure S2 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

  2026-06-17

• Figure S1 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

  2026-06-17

• Figure S4 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

  2026-06-17

• Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-06-11

• Inhibiting the interaction between the mitochondrial receptor Tom70 and SARS CoV 2 Orf9b with small molecules

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-04-27

• Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells

  Cell · 2026-04-20

• The COX2-PGE2-PKA Axis Suppresses Antiviral Immunity by Inhibiting mtDNA-Dependent STING Activation

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-04-06

• The ADAPT learning cancer treatment system: ARPA-H’s initiative to revolutionize cancer therapy

  Cancer Cell · 2026-01-08 · 1 citations

• Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy In Vivo

  Journal of Medicinal Chemistry · 2025-12-17

• Functional diversification of the cephalopod proteome by RNA-editing

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-16

• Combinatorial protein engineering identifies potent CRISPR activators with reduced toxicity

  Nature Communications · 2025-11-20

• Author response: The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2

  2025-11-19

• The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2

  eLife · 2025-11-19

• The lactate sensor NDRG3 decelerates ER-to-Golgi transport through interaction with the long isoform of syntaxin-5

  Proceedings of the National Academy of Sciences · 2025-11-18

• Author Correction: Brahma safeguards canalization of cardiac mesoderm differentiation

  Nature · 2025-11-18

• Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor

  Molecular Aspects of Medicine · 2025-11-10

• Human Genetic Variation Associates With Infection by Derived Ugandan <i>M. tuberculosis</i> LineagePreprint

  The Journal of Infectious Diseases · 2025-11-02